Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
Abstract Medulloblastoma (MB) is the most common aggressive paediatric brain tumour and, despite the recent progress in the treatments of MB patients, there is still an urgent need of complementary or alternative therapeutic options for MB infants. Cyclin Dependent Kinase inhibitors (CDKi) are at th...
Enregistré dans:
Auteurs principaux: | Marta Buzzetti, Sonia Morlando, Dimitrios Solomos, Ammara Mehmood, Alexander W. I. Cox, Mattia Chiesa, Yuri D’Alessandra, Michela Garofalo, Caroline H. Topham, Gianpiero Di Leva |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5a64e631106b44d6a6c20f70baf716a7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The transcriptional landscape of Shh medulloblastoma
par: Patryk Skowron, et autres
Publié: (2021) -
Wnt activation as a therapeutic strategy in medulloblastoma
par: Branavan Manoranjan, et autres
Publié: (2020) -
Modeling medulloblastoma in vivo and with human cerebellar organoids
par: Claudio Ballabio, et autres
Publié: (2020) -
CREB signaling activity correlates with differentiation and survival in medulloblastoma
par: Inna Armandari, et autres
Publié: (2021) -
Pre-RC Protein MCM7 depletion promotes mitotic exit by Inhibiting CDK1 activity
par: Dianpeng Zheng, et autres
Publié: (2017)